The lancet. Diabetes & endocrinology
-
Lancet Diabetes Endocrinol · Aug 2014
Randomized Controlled Trial Multicenter StudyIntensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
The benefits of intensified glycaemic control after acute myocardial infarction are uncertain. We report the 20 year follow-up results of the first Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial. ⋯ Swedish Heart-Lung Foundation, Kronoberg County Council.